1. Overexpression of ADAM9 in oral squamous cell carcinoma
   Pattaramon Tanasubsinn et al, 2017, Oncology Letters CrossRef
2. Preclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody–drug Conjugate Targeting ADAM9-expressing Tumors
   Juniper A. Scribner et al, 2022, Molecular Cancer Therapeutics CrossRef
3. ADAM9 expression promotes an aggressive lung adenocarcinoma phenotype
   Céline Mongaret Kossmann et al, 2017, Tumor Biology CrossRef
4. Exploring the oncogenic and tumor-suppressive roles of Circ-ADAM9 in cancer
   Md Sadique Hussain et al, 2024, Pathology - Research and Practice CrossRef
5. MicroRNA-302a suppresses cell proliferation, migration and invasion in osteosarcoma by targeting ADAM9
   Xiaoming Yang et al, 2017, Molecular Medicine Reports CrossRef
6. An Overview of ADAM9: Structure, Activation, and Regulation in Human Diseases
   Cheng-Wei Chou et al, 2020, International Journal of Molecular Sciences CrossRef
7. Involvement of the A disintegrin and metalloproteinase 9 in oral cancer cell invasion
   Worakanya Buranaphatthana et al, 2021, European Journal of Oral Sciences CrossRef
8. Natural Products with Activity against Lung Cancer: A Review Focusing on the Tumor Microenvironment
   Yue Yang et al, 2021, International Journal of Molecular Sciences CrossRef
9. The pleiotropic roles of ADAM9 in the biology of solid tumors
   Victor O. Oria et al, 2018, Cellular and Molecular Life Sciences CrossRef
10. miR-126 inhibits cell growth, invasion, and migration of osteosarcoma cells by downregulating ADAM-9
    Liangdong Jiang et al, 2014, Tumor Biology CrossRef
11. HDGF and ADAM9 are novel molecular staging biomarkers, prognostic biomarkers and predictive biomarkers for adjuvant chemotherapy in surgically resected stage I non-small cell lung cancer
    Jun Zhang et al, 2014, Journal of Cancer Research and Clinical Oncology CrossRef
12. MicroRNA-126 Overexpression Inhibits Proliferation and Invasion in Osteosarcoma Cells
    Shuaihua Wang et al, 2016, Technology in Cancer Research & Treatment CrossRef
13. Free-flow zone electrophoresis facilitated proteomics analysis of heterogeneous subpopulations in H1299 lung cancer cells
    Amir Sohail et al, 2022, Analytica Chimica Acta CrossRef
14. MicroRNA-543 inhibits proliferation, invasion and induces apoptosis of glioblastoma cells by directly targeting ADAM9
    Tao Ji et al, 2017, Molecular Medicine Reports CrossRef
15. RNAi-mediated A disintegrin and metalloproteinase 9 gene silencing inhibits the tumor growth of non-small lung cancer in vitro and in vivo
    LIANG CHANG et al, 2015, Molecular Medicine Reports CrossRef
16. Serum concentrations of A disintegrin and metalloproteinase 9 (ADAM9) mRNA as a promising novel marker for the detection of pulmonary sarcoidosis
    Jingyu Liu et al, 2013, Journal of International Medical Research CrossRef
17. Research Progress of ADAM9 in the Biology of Solid Tumors
    莉金 朱, 2020, Advances in Clinical Medicine CrossRef
18. Oncologic Outcomes of Surgery Versus SBRT for Non–Small-Cell Lung Carcinoma: A Systematic Review and Meta-analysis
    Michiel A. Ijsseldijk et al, 2021, Clinical Lung Cancer CrossRef
19. Video-assisted thoracoscopic surgery and thoracotomy during lobectomy for clinical stage I non-small-cell lung cancer have equivalent oncological outcomes: A single-center experience of 212 consecutive resections
    CHUNHUA LIU et al, 2015, Oncology Letters CrossRef
20. A disintegrin and metalloproteinase domain 9 facilitates SARS-CoV-2 entry into cells with low ACE2 expression
    Ivonne Melano et al, 2023, Microbiology Spectrum CrossRef